Cargando…
Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial
BACKGROUND: Vernal keratoconjunctivitis (VKC) is a bilateral, recurrent, chronic conjunctival inflammatory disease with seasonal exacerbations. This study aimed to assess the efficacy and safety of tacrolimus 0.03% eye ointment in the management of chronic VKC. METHODS: This was an open-label, prosp...
Autores principales: | Eltagoury, Mahmoud, Abou Samra, Waleed, Ghoneim, Ehab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Virtual Ophthalmic Research Center
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445306/ https://www.ncbi.nlm.nih.gov/pubmed/37641784 http://dx.doi.org/10.51329/mehdiophthal1446 |
Ejemplares similares
-
Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus
ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023) -
Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019) -
Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012) -
Efficacy and safety of low-dose topical tacrolimus in vernal keratoconjunctivitis
por: Shoughy, Samir S, et al.
Publicado: (2016) -
Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis
por: Al-Amri, Abdulrahman Mohammed, et al.
Publicado: (2017)